Haruka Takata - Concepedia

Author

Haruka Takata

Tokushima University ORCID

Also Known As

HARUKA TAKATA, Haruka Takata

Publications

301

Citations

H-Index

Concepts

All Affiliations

Tokushima University Zagazig University University of Ha'il Minia University

About

Haruka Takata is an author at Tokushima University specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	234
2	Immunology	6	6	234
3	Cell Biology	4	4	168
4	Pathology	2	2	127
5	Biomolecular Engineering	1	1	29

Haruka Takata

Publications

246

Citations

H-Index

Page 1

	Year	Citations
Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice Sherif E. Emam, Nehal E. Elsadek, Amr S. Abu Lila, Journal of Controlled Release Blood Clearance PhenomenonPegylated ExosomesHematologyImmunologyPathology	2021	77
Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon Marwa Mohamed El Sayed, Haruka Takata, Taro Shimizu, Journal of Controlled Release InflammationAccelerated Blood ClearanceAutoimmune DiseaseAbc PhenomenonImmunology	2020	50
Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice Nehal E. Elsadek, Amr S. Abu Lila, Sherif E. Emam, European Journal of Pharmaceutics and Biopharmaceutics Accelerated Blood ClearanceAutoimmune DiseaseMedicineHematologyImmunology	2020	38
Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route Haruka Takata, Taro Shimizu, Rina Yamade, Journal of Controlled Release Lipid PreparationImmunologyEndocytic PathwayAdministration RouteCellular Biochemistry	2023	29
Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice Nehal E. Elsadek, Eri Hondo, Taro Shimizu, Molecular Pharmaceutics Circulation Half-livesImmunologyBiological TherapyPharmacotherapyImmunotherapeutics	2020	28
Nucleic acids delivered by PEGylated cationic liposomes in systemic lupus erythematosus-prone mice: A possible exacerbation of lupus nephritis in the presence of pre-existing anti-nucleic acid antibodies Haruka Takata, Taro Shimizu, Yoshino Kawaguchi, International Journal of Pharmaceutics Autoimmune DiseaseSystemic Lupus Erythematosus TreatmentLupusPegylated Cationic LiposomesLupus Nephritis	2021	12
Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice Sherif A. Gaballa, Taro Shimizu, Haruka Takata, Molecular Pharmaceutics	2024	12

Page 1